ROBERT A INGRAM Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT A INGRAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT A INGRAM. ROBERT A INGRAM is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in CREE INC ($CREE) and Director in REGENERON PHARMACEUTICALS INC ($REGN) and Director in Valeant Pharmaceuticals International, Inc. ($BVF) and Director in Edwards Lifesciences Corp ($EW) and Director in Novan, Inc. ($NOVN) and Director in Black Diamond Therapeutics, Inc. ($BDTX).
ROBERT A INGRAM in BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT A INGRAM: Director
Holdings: 75,013 shares
Current Value: $425,324
Latest Transaction: Mar 02 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT A INGRAM in BIOCRYST PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BVF, BCRX, BDTX, CREE, EW, NOVN, REGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 10.78 | 1,739 | 18,746 | 75,013 | 73.3 K to 75 K (+2.37 %) |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.11 | 3,669 | 18,749 | 73,274 | 69.6 K to 73.3 K (+5.27 %) |
Sep 02 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.15 | 4,518 | 18,750 | 69,605 | 65.1 K to 69.6 K (+6.94 %) |
Jun 03 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.50 | 4,171 | 18,749 | 65,087 | 60.9 K to 65.1 K (+6.85 %) |
May 14 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
Mar 03 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 3.00 | 6,250 | 18,750 | 60,916 | 54.7 K to 60.9 K (+11.43 %) |
Mar 03 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 3.00 | 6,250 | 18,750 | 60,916 | 54.7 K to 60.9 K (+11.43 %) |
Dec 03 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 2.85 | 6,578 | 18,747 | 54,666 | 48.1 K to 54.7 K (+13.68 %) |
Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Buy | P | 1.45 | 20,000 | 29,000 | 48,088 | 28.1 K to 48.1 K (+71.20 %) |
Sep 04 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 2.99 | 6,270 | 18,747 | 28,088 | 21.8 K to 28.1 K (+28.74 %) |
May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 | |
Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
Jun 04 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 6.43 | 2,916 | 18,750 | 21,818 | 18.9 K to 21.8 K (+15.43 %) |
Jun 04 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 6.43 | 2,916 | 18,750 | 21,818 | 18.9 K to 21.8 K (+15.43 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.97 | 3,772 | 18,747 | 18,902 | 15.1 K to 18.9 K (+24.93 %) |
Dec 04 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.08 | 3,690 | 18,745 | 15,130 | 11.4 K to 15.1 K (+32.26 %) |
Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.10 | 3,676 | 18,748 | 11,440 | 7.8 K to 11.4 K (+47.35 %) |
Jun 02 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.15 | 1,941 | 9,996 | 7,764 | 5.8 K to 7.8 K (+33.33 %) |
May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
Mar 02 2017 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 6.24 | 1,602 | 9,996 | 5,823 | 4.2 K to 5.8 K (+37.95 %) |
Dec 02 2016 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.59 | 1,788 | 9,995 | 4,221 | 2.4 K to 4.2 K (+73.49 %) |
Sep 06 2016 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.11 | 2,433 | 10,000 | 2,433 | 0 to 2.4 K |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
Aug 07 2015 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 14.88 | 18,750 | 279,000 | 18,750 |
Page: 1